Nebius Surges on Huang Endorsement, But Execution Hurdles Remain

What happened

Q1 revenue surged 684% year-over-year to $399 million, and Jensen Huang's public endorsement at Computex has strengthened Nebius's credibility, accelerating its transition from speculative AI play to strategic infrastructure provider. However, the DeepValue master report maintains a WAIT rating, emphasizing that the next 6–9 months hinge on proof of on-time tranche deployments and non-dilutive financing. While the endorsement and strong demand are positive, elevated short interest (~21% of float) signals lingering skepticism. The core risk remains whether Nebius can deliver capacity on schedule and secure debt financing without triggering dilution.

Implication

The endorsement improves credibility but does not alter the fundamental thesis. Wait for Q3 2026 capacity delivery evidence and debt financing terms before building a position. The attractive entry remains around $180, with a trim above $260.

Thesis delta

The Jensen Huang endorsement and Q1 results reduce near-term skepticism and reinforce demand strength, but they do not resolve the core execution and funding checkpoints. The need to see on-time capacity delivery and non-dilutive financing is unchanged.